Clinical Trial Update: uPAR-PET/MRI in Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating uPAR-PET/MRI in glioblastoma multiforme; the update lists the study status as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Glioblastoma Multiforme | Phase 2 | Status: UNKNOWN